ANAVEX LIFE SCIENCES CORP. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/19fa1c00-bae2-47f8-9f99-bc78af441cf7/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-51.4M | 2024-10-01 – 2025-09-30 | evidence 0001731122-25-001596 |
| FY 2024 | $-52.9M | 2023-10-01 – 2024-09-30 | evidence 0001731122-24-002041 |
| FY 2023 | $-55.8M | 2022-10-01 – 2023-09-30 | evidence 0001731122-25-001596 |
| FY 2022 | $-51.0M | 2021-10-01 – 2022-09-30 | evidence 0001731122-23-002197 |
| FY 2021 | $-42.0M | 2020-10-01 – 2021-09-30 | evidence 0001731122-23-002197 |
| FY 2020 | $-31.1M | 2019-10-01 – 2020-09-30 | evidence 0001731122-22-002062 |
| FY 2014 | $-3.0M | 2013-10-01 – 2014-09-30 | evidence 0001062993-14-007294 |
| FY 2013 | $-31.4M | 2004-01-23 – 2014-03-31 | evidence 0001062993-14-003434 |
| FY 2012 | $-28.4M | 2004-01-23 – 2013-03-31 | evidence 0001062993-13-002655 |
| FY 2011 | $-26.5M | 2004-01-23 – 2012-03-31 | evidence 0001062993-12-001798 |
| FY 2010 | $-5.6M | 2009-10-01 – 2010-09-30 | evidence 0001062993-11-005004 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).